RFA-CK-25-035: Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya
Closed
This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2024.
Centers for Disease Control and Prevention - ERA offered grants of up to $3.0 million (at least $1.5 million) to nonprofits, colleges and universities, state and local governments, tribes and businesses. It expected to make one award worth $13.0 million in total. Applications closed on February 12, 2025.
From the official notice on Grants.gov, last changed November 25, 2024. Checked November 7, 2026.
- Award ceiling$3.0 million
- Award floor$1.5 million
- Total funding$13.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | November 25, 2024 |
|---|---|
| Deadline | February 12, 2025 |
| Archived by Grants.gov | March 14, 2025 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes and businesses.
All 14 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Foreign Organizations/Institutions are eligible to apply. To be considered eligible, the application should have a demonstrated presence in Western Kenya, including evidence of prior malaria research conducted in collaboration with the KEMRI Center for Global Health Research and a letter of support and collaboration from the KEMRI Center for Global Health Research Malaria Program director stating their intention to collaborate on this project.
Is this a realistic fit?
- Past Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention awards averaged $1.7 million; this notice allows up to $3.0 million per award.
- Most of the program's money (51% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The purpose of this notice of funding opportunity (NOFO) is to support research to assist with the implementation of malaria focused operations research, surveillance, and monitoring and evaluation activities in Kenya. Through this NOFO, CDC seeks to fund critical operations research and evaluation activities with the potential to yield high impact public health findings and to improve strategies that will decrease the overall burden of malaria and increase the health and well-being of affected populations in Kenya.
Who has won Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention grants before
From fiscal 2021 to 2025, Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention (93.326) awarded $345 million across 205 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Washington State University | Washington | 2 | $23.2 million |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 2 | $19.6 million |
| International Centre for Diarrhoeal Disease Research, Bangladesh | 2 | $13.3 million | |
| Liverpool School of Tropical Medicine | 1 | $10.6 million | |
| California Department of Public Health | California | 1 | $10.3 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-CK-25-035 still open?
No. It closed on February 12, 2025. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.
Who can apply for Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya?
Centers for Disease Control and Prevention - ERA accepted applications from nonprofits, colleges and universities, state and local governments, tribes and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya?
Closed February 12, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $3.0 million each. About $13.0 million in total for one award.
Who has won Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention grants before?
The largest recipients over five fiscal years were Washington State University, Association of Public Health Laboratories, Inc. (the), International Centre for Diarrhoeal Disease Research, Bangladesh. The program made 205 awards worth $345 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)